Understand strong vs weak evidence in medical research, including evidence hierarchy, bias, and expectation control. A clear guide with relevance to rare diseases and clinical decision-making.
What Strong and Weak Evidence Mean in Medical Research
Understand strong vs weak evidence in medical research, including evidence hierarchy, bias, and expectation control. A clear guide with relevance to rare diseases and clinical decision-making.
The Diagnostic Odyssey: Why Rare Diseases Are Hard to Identify
The diagnostic odyssey in rare diseases often takes 4–5 years. Discover why symptom overlap, misdiagnosis, system barriers, and genetic limits cause delays, plus emerging solutions.
Coping As A Family After A Rare Disease Diagnosis
Learn how families handle rare disease diagnoses with expert guidance, emotional support, and practical tips for daily life and care.
How Health Policy Shapes Access to Rare Disease Treatments
Explore shifts in rare disease policy and how they impact patient access to life-saving orphan drugs.
Transitioning From Paediatric To Adult Care:Preparing Early
Understand the challenges rare disease young patients face when transitioning to adult care and why preparation should begin in early adolescence.
Understanding Multidisciplinary Clinics for Rare Diseases
Multidisciplinary clinics for rare diseases unite specialists from different fields to collaborate on diagnosis and treatment, helping patients receive faster answers, coordinated care, and access to advanced therapies."
How Researchers Confirm a Link Between a Gene and a Disease
How researchers prove that a gene causes a disease. A clear guide to the scientific methodology, evidence standards, and validation process used in rare disease research.
Why Rare Disease Treatments Take Longer To Reach Patients
For millions living with rare diseases, effective treatments remain out of reach. Learn why drug development takes longer for rare conditions and how innovation is starting to close the gap.
What Prevalence and Incidence Mean and Why the Difference Matters
Understanding the difference between prevalence and incidence is key to interpreting health data, planning care, and supporting rare disease communities.
How Rare Disease Research Is Funded
Rare disease research funding is limited but creative. Discover government grants, patient-led support, international alliances, networks, and emerging models driving progress for 7,000+ conditions.